MRI T staging matched DRE for predicting prostate cancer outcomes, supporting its use in modern risk classification systems.

A study explored preoperative MRI’s prognostic ability compared with digital rectal exam (DRE) among men who had prostate cancer surgery.

MRIs are powerful tools in the cancer-fighting arsenal, but despite their efficacy, they aren't infallible, and some cancers ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests A new meta-analysis by investigators from Brigham and ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...

An artificial intelligence system slightly outperformed radiologists using PI-RADS at detecting clinically significant prostate cancer. A trained artificial intelligence (AI) system discriminated ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new ...

France: Researchers have found in a new study of 4,425 men that MRI-based staging performed comparably to traditional digital rectal examination (DRE) in predicting prostate cancer outcomes, including ...